Daily Cancer News

OMNI Health Media is a leading online provider of Daily Cancer News. OMNI’s Daily Cancer News provides summaries of new treatment strategies as they are discovered and reported by physicians and scientists around the world. Our mission is to provide this news, including results of recent clinical trials evaluating cancer therapies and supportive care strategies, to better educate patients and their caregivers, ensuring timely access to the best cancer care available.

CancerConnect Cancer Commuity & Discussions

Share


Latest Cancer News


Role of Tumor Size and Estrogen-Receptor Status in Decline in Breast Cancer Deaths (August 4, 2015)

In light of a general decline in breast cancer death since the late 1980s, research has now turned to how type and stage of disease affect survival among different women. These findings, which considered... Continue Reading

FDA Grants Breakthrough Therapy Designation to LENVIMA™ for the Potential Treatment of Metastatic Renal Cell Carcinoma (August 3, 2015)

Eisai Inc. has announced that the U.S. Food and Drug Administration (FDA) granted LENVIMA™ (lenvatinib), the company’s multiple receptor tyrosine kinase inhibitor, Breakthrough Therapy designation... Continue Reading

Promising Survival for AML Patients Treated with Stem Cells from Related Half Matched Donor (July 30, 2015)

Patients with acute myeloid leukemia (AML) may have a promising new treatment option. Research shows that stem cell transplant from a “half matched” related donor plus chemotherapy results in similar... Continue Reading

Study of Opdivo® versus Afinitor® Stopped Early when Opdivo Demonstrated Better Survival (July 29, 2015)

Patients with advanced or metastatic kidney cancer who are treated with Opdivo® (nivolumab) have better overall survival than those treated with Afinitor® (everolimus), according to findings from a Phase... Continue Reading

Lifestyle and Cancer: Can Diet and Exercise Make a Difference? Join us on August 4th! (July 28, 2015)

Exercise and Good Nutrition During and After Cancer Treatment: Your Questions Answered! August 4th, 6:30-7:30 PM, EST Tune in here. Can diet and exercise make a difference in your health and well being... Continue Reading

Deadly and distinctive: Cancer caused by gene deletions (July 28, 2015)

By Bill Hathaway A deadly form of T cell lymphoma is caused by an unusually large number gene deletions, making it distinct among cancers, a new Yale School of Medicine study shows. Researchers conducted... Continue Reading

Bug out: Killing common bacteria may curb stomach cancer, studies show (July 27, 2015)

The H. pylori bacterium is a top cause of stomach cancerCourtesy of the Salama Lab at Fred Hutch By Bill Briggs / Fred Hutch News Service This bug loves our guts — living silently in most folks, causing... Continue Reading

Blincyto® in Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia Appears Promising (July 23, 2015)

Biotechnology company Amgen has announced that their immunotherapy drug Blincyto® (blinatumomab) appears promising in the treatment of adults with Philadelphia chromosome-positive (Ph+) acute lymphoblastic... Continue Reading

Investigational T-cell Receptor Therapy Achieves Encouraging Clinical Responses in Multiple Myeloma Patients, Penn-led Study Finds (July 22, 2015)

Results from a clinical trial investigating a new T cell receptor (TCR) therapy that uses a person’s own immune system to recognize and destroy cancer cells demonstrated a clinical response in 80 percent... Continue Reading

Cancers Caught During Screening Colonoscopy are More Survivable (July 21, 2015)

Patients whose colorectal cancer (CRC) is detected during a screening colonoscopy are likely to survive longer than those who wait until they have symptoms before having the test, according to a study... Continue Reading

FDA Approves Iressa for Treatment of Patients with Metastatic Non Small Cell Lung Cancer (July 20, 2015)

The U. S. Food and Drug Administration approved IRESSA (gefitinib) for the treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR)... Continue Reading

FDA Grants Fast Track Designation to Toca 511 & Toca FC for Treatment of High Grade Glioblastoma (July 16, 2015)

Tocagen Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its lead oncology product, Toca 511 & Toca FC, for the treatment of recurrent high... Continue Reading

More Men with Low-Risk Prostate Cancer Are Delaying Treatment until Progression (July 15, 2015)

Increasingly more men with low-risk, early-stage prostate cancer appear to choose active surveillance (or watchful waiting) instead of treatment. As a result, they’re avoiding the risk of long-term side... Continue Reading

Ludwig Cancer Research and Cancer Research Institute Evaluate Immunotherapeutic Strategies for Brain Cancer and Other Types of Solid Tumors (July 14, 2015)

The trials are being conducted through the CVC Clinical Trials Network in collaboration with MedImmune, the global biologics research and development arm of AstraZeneca. The CVC Clinical Trials Network... Continue Reading

theGIConnection and the Inflammatory Bowel Disease Support Foundation Partner to Provide Crohn’s Disease and Ulcerative Colitis Patients with Virtual Support Community (July 13, 2015)

July 13, 2015  – Fort Worth TX/Sun Valley ID —OMNI Health Media (OMNI) and the Inflammatory Bowel Disease Support Foundation (IBDSF) are pleased to announce a partnership with TheGIConnection... Continue Reading

Researchers Recruit Herpes Virus as Part of Brain Cancer Treatment (July 13, 2015)

A therapy that uses the herpes virus to make tumors more vulnerable to treatment appears promising in the treatment of glioblastoma multiforme (GBM), a form of brain cancer. These findings were presented... Continue Reading

New Guidelines on Radiation Therapy After Surgery for Endometrial Cancer (July 9, 2015)

The American Society of Clinical Oncology (ASCO) today issued an endorsement of the American Society for Radiation Oncology (ASTRO) clinical practice guideline on postoperative radiation therapy for women... Continue Reading

Cancer treatment quackery fuels concern among doctors, FDA (July 8, 2015)

Be wary of possible side effects, drug interactions when using alternative health supplements, physicians caution One potentially fake cancer drug sold online can actually cause malignancies. One enema... Continue Reading

More Cancer News

CancerConnect Cancer Commuity & Discussions


Cancer Types



Headline News by Cancer Type


Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Facebook Twitter RSS